ArticleAmerican heart journal2021

Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE).

Andrew P Ambrosy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.